Anti-Tumor Activity of Novel Nimotuzumab-Functionalized Gold Nanoparticles as a Potential Immunotherapeutic Agent against Skin and Lung Cancers

The epidermal growth factor receptor (EGFR) is vital for many different types of cancer. Nimotuzumab (NmAb), an anti-EGFR monoclonal antibody (mAb), is used against some of EGFR-overexpressed cancers in various countries. It targets malignant cells and is internalized via receptor-mediated endocytos...

Descripción completa

Detalles Bibliográficos
Autores principales: Anisuzzman, Mohammad, Komalla, Varsha, Tarkistani, Mariam Abdulaziz M., Kayser, Veysel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456021/
https://www.ncbi.nlm.nih.gov/pubmed/37623652
http://dx.doi.org/10.3390/jfb14080407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456021/
https://www.ncbi.nlm.nih.gov/pubmed/37623652
http://dx.doi.org/10.3390/jfb14080407

Ejemplares similares